CHOP’s Food Allergy Research Highlighted Following FDA’s Approval of Palforzia
Published on
CHOP’s Food Allergy Center was one of the research sites that helped test and develop the new drug.
Published on
CHOP’s Food Allergy Center was one of the research sites that helped test and develop the new drug.
Published on
Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.
Published on
Poor sleep habits and sleep disorders are very common in early childhood, especially in children exposed to multiple family and environmental risks like parental depression and poverty, say researchers from Children’s Hospital of Philadelphia (CHOP) in a study recently published in the journal Sleep.
Published on
Dr. Spergel was honored for his research in pediatric food allergies.
Published on
The first-of-its-kind treatment can reduce a child's allergic reaction to peanuts.
Published on
Previous research has linked exposure to bisphenol A (BPA) in the womb with higher rates of obesity and diabetes later in life, but the biological mechanisms driving those changes have largely remained a mystery.
Published on
The $200,000 award will fund research to develop a novel therapeutic that ignites the immune system and could act as a stand-alone treatment, as well as boost the effectiveness of existing immunotherapies.
Published on
A decade after the MOMS trial, new findings show significant physical and emotional benefits in school-age children who had prenatal surgery for spina bifida.
Published on
Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients. A multidisciplinary team of researchers from Children’s Hospital of Philadelphia (CHOP) redesigned the hospital’s standard treatment for the infection and reduced albuterol use without compromising care.
Published on
A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help distinguish an adult-onset form of diabetes sharing many type 1 diabetes (T1D) characteristics from pediatric-onset T1D.